Article

ASCRS 2023: Using IOL to alter choroidal thickness after cataract surgery

Author(s):

In a presentation at the American Society for Cataract and Refractive Surgery annual meeting in San Diego, Erisa Yotsukura, MD, PhD, offered details of a study examining an IOL that transmits violet light and a second option that does not, and they believe this can affect differences in the choroidal thickness after cataract surgery.

a close image of an IOL (Image Credit: AdobeStock/Mohammed)

(Image Credit: AdobeStock/Mohammed)

A team of investigators, including Erisa Yotsukura, MD, PhD, from the Department of Ophthalmology, Keio University School of Medicine, Tokyo, evaluated an IOL that transmits violet light and an IOL that did not. This switch, they believe, can affect differences in the choroidal thickness after cataract surgery.

The researchers evaluated 402 patients (402 eyes) who were to undergo cataract surgery.

The patients were followed for 1 year after the surgery and had been randomly assigned for implantation with ZCB00V IOL (Johnson & Johnson) (group Z, 202 cases; mean age, 68.2 years), which does not transmit violet light. or the W-60R IOL (Santen Pharmaceutical) (group W, 200 cases; mean age, 69.1 years), which transmits violet light partially.

The subfoveal choroidal thickness was measured before and at 3, 6, 9, and 12 months postoperatively. The changes in the choroidal thicknesses were compared and analyzed between the 2 groups from 3 to 12 months postoperatively.

Differences in the IOLs

Preoperatively, there were no significant difference between the 2 IOLs in the logarithm of the minimum angle of resolution best-corrected visual acuity (logMAR BCVA) and the corneal refractions.

The differences in the noncycloplegic objective refractions, the axial lengths and the choroidal thicknesses in the Z and W groups reached significance. They were, respectively, -3.97 and -2.19 D (p<0.01), 24.89 and 24.13 mm (p<0.001), and 213.0 and 236.2 μm (p=0.01).

Postoperatively, from 3 to 12 months, the mean changes in the logMAR BCVAs, noncycloplegic objective refractions, corneal refractions and axial lengths did not reach significance.

However, the changes in the choroidal thicknesses during the same time period postoperatively did reach significance. They were, respectively, -1.79 and 3.48 μm (p = 0.01).

“The IOL that transmits different wavelengths of light during cataract surgery may cause a difference in the postoperative change in the choroidal thickness,” the investigators concluded.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Deb Ristvedt, DO, on medications, lasers, and lifestyle in glaucoma management
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.